Cytek biosciences inc. + press release
WebFeb 28, 2024 · Provides full year 2024 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over full year 2024. FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) ( Nasdaq: CTKB) today reported financial results for the fourth quarter and year ended December … WebFeb 13, 2024 · Cytek Biosciences, Inc. Investor Conference Call. ... This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject …
Cytek biosciences inc. + press release
Did you know?
WebFeb 13, 2024 · Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin. CTKB February 13, 2024. Sale of assets related to Flow Cytometry & … WebCYTEK BIOSCIENCES, INC. : Press releases relating to CYTEK BIOSCIENCES, INC. Investor relations Nasdaq: CTKB Nasdaq
WebApr 12, 2024 · A high-level overview of Cytek Biosciences, Inc. (CTKB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebFeb 13, 2024 · SALUGGIA (Italy), and FREMONT, California (USA), February 13, 2024 - DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today …
Web2 days ago · Trusted News Since 1995 A service for global professionals · Tuesday, April 11, 2024 · 627,334,857 Articles · 3+ Million Readers Home ••• Newswires by Industry • … Web04/11/2024 Press release Distributed by Public on 04/11/2024 16:05. Statement of Changes in Beneficial Ownership - Form 4. FORM 4. ... C/O CYTEK BIOSCIENCES, INC. , 47215 LAKEVIEW BOULEVARD 3. Date of Earliest Transaction (Month/Day/Year) (Street) FREMONT CA 94538 4. If Amendment, Date Original Filed(Month/Day/Year)
WebOct 7, 2024 · About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. ... This press release contains ...
WebApr 13, 2024 · Conference Call Scheduled for Tuesday, April 18 at 4:30pm ET. SOUTH EASTON, MA / ACCESSWIRE / April 13, 2024 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Fiscal Year 2024 financial results and to provide a business … razer opus gaming modeWebApr 10, 2024 · Press release - QY Research, Inc - Spectral Flow Cytometry Market Size, Trend Analysis, Opportunities And Future Demand Foreseen by 2029 Sony Biotechnology, Cytek Biosciences, BD Biosciences ... razer opus singaporeWebNov 3, 2024 · Nov 3, 2024. FREMONT, Calif., Nov. 03, 2024 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today … razer opus blackWebFeb 28, 2024 · FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. ... This press release contains forward-looking statements within the meaning of the Private Securities Litigation ... razer opus resetWebApr 13, 2024 · Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CEO Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock in a transaction that occurred on Monday, April 10th.The stock was sold at an average price of $8.88, for a total transaction of $177,600.00. Following the sale, the chief executive officer now owns 7,684,439 shares … razer opus vs barracuda proWeb17 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Cytek Biosciences (CTKB) razer opus opinionesWebAurogene Srl’s Post Aurogene Srl 953 followers 1y razer opus x